Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China

Antimicrob Agents Chemother. 2013 Apr;57(4):1935-7. doi: 10.1128/AAC.02445-12. Epub 2013 Jan 14.

Abstract

A carbapenem-resistant clinical isolate of Escherichia coli, which lacked OmpF and OmpC porins, carried a marR mutation and expressed a functional yedS, a normally nontranslated gene. MarR and YedS are described here as having effects on the ability of this strain to resist carbapenems. Additionally, expression of YedS was regulated by the small RNA MicF in a MarA-dependent way. These findings illustrate how broadly bacteria can mutate within a selective clinical setting, in this case, resistance to carbapenems, by altering three porin genes and one regulatory gene.

MeSH terms

  • Carbapenems / pharmacology
  • China
  • Electrophoresis, Polyacrylamide Gel
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism*
  • Gene Expression Regulation, Bacterial / drug effects
  • Gene Expression Regulation, Bacterial / genetics
  • Molecular Sequence Data
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism*

Substances

  • Carbapenems
  • Escherichia coli Proteins
  • MarR protein, E coli
  • Repressor Proteins

Associated data

  • GENBANK/JX392406